scout
|Videos|January 9, 2017

The Possibility for Immunotherapy in Neoadjuvant Bladder Cancer Treatment

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses the possibility for immunotherapy as a neoadjuvant treatment in bladder cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME